Analytical coupled-wave model for photonic crystal quantum cascade lasers

A coupled-wave model is developed for photonic-crystal quantum cascade lasers. The analytical model provides an efficient analysis of full three-dimensional large-area device structure, and the validity is confirmed via simulations and previous experimental results.Comment: 21 pages and 8 figure

Time to Clinical Benefit of Intensive Blood Pressure Lowering in Patients 60 Years and Older With Hypertension

Importance Recent guidelines recommend a systolic blood pressure (BP) goal of less than 150 mm Hg or even 130 mm Hg for adults aged 60 years or older. However, harms from intensive BP treatments occur immediately (eg, syncope, fall), and benefits for cardiovascular event reduction emerge over time. Therefore, harms with low chance of benefit need to be clearer, particularly for those with limited life expectancy. Objective To estimate the time needed to potentially derive clinical benefit from intensive BP treatment in patients 60 years and older. Design, Setting, and Participants This secondary analysis included individual patient data from published randomized clinical trials with 27 414 patients 60 years or older with hypertension. Patient-level survival data were reconstructed when the original data were not available. Published trials were identified by searching PubMed until October 15, 2021. Exposures Intensive BP lowering vs standard BP lowering with the treat-to-target design. Main Outcomes and Measures Major adverse cardiovascular event (MACE) defined by each trial, which was broadly similar with all trials including myocardial infarction, stroke, and cardiovascular mortality. Results Six trials (original data from 2 trials and reconstructed data from 4 trials) with 27 414 participants (mean age, 70 years; 56.3% were women) were included in the analysis. Intensive BP treatment with a systolic BP target below 140 mm Hg was significantly associated with a 21% reduction in MACE (hazard ratio, 0.79; 95% CI, 0.71-0.88; P < .001). On average, 9.1 (95% CI, 4.0-20.6) months were needed to prevent 1 MACE per 500 patients with the intensive BP treatment (absolute risk reduction [ARR], 0.002). Likewise, 19.1 (95% CI, 10.9-34.2) and 34.4 (95% CI, 22.7-59.8) months were estimated to avoid 1 MACE per 200 (ARR, 0.005) and 100 (ARR, 0.01) patients, respectively. Conclusions and Relevance In this analysis, findings suggest that for patients 60 years and older with hypertension, intensive BP treatment may be appropriate for some adults with a life expectancy of greater than 3 years but may not be suitable for those with less than 1 year

Time‐weighted blood pressure with cardiovascular risk among patients with or without diabetes

Background: Usual measures of blood pressure (BP) do not account for both the magnitude and duration of exposure to elevated BP over time. We aimed to demonstrate the effect of a novel time‐weighted BP on cardiovascular outcomes using a post hoc analysis of two published randomized trials. Hypothesis: Time‐weighted blood pressure is associated with cardiovascular risk among patients with or without diabetes. Methods: The limited‐access ACCORD and SPRINT data sets were used for the current study. Time‐weighted BP is obtained by dividing cumulative BP by the total follow‐up time. Time‐weighted BP burden above a threshold is also determined after deriving the time‐weighted BP by re‐zeroing the interpolated pressure values at two different hypertension thresholds (>140/90 and >130/80 mmHg). Results: Eighteen thousand five hundred forty‐one patients from the two clinical trials were enrolled in this study. A J‐curve relation was observed between time‐weighted BP and major cardiovascular events (MACE). The systolic blood pressure (SBP) burden independently predicted MACE across the two trials at different thresholds (ACCORD: SBP > 130 mmHg, HR = 1.05 [1.03−1.06]; SBP > 140 mmHg, HR = 1.06 [1.04−1.08]; SPRINT: SBP > 130 mmHg, HR = 1.04 [1.03−1.05]; SBP > 140 mmHg, HR = 1.05 [1.04−1.07]). Consistent results were found for diastolic blood pressure (DBP) burden (ACCORD: DBP > 80 mmHg, HR = 1.10 [1.06−1.15]; DBP > 90 mmHg, HR = 1.20 [1.11−1.30]. SPRINT: DBP > 80 mmHg, HR = 1.06 [1.02−1.09]; DBP > 90 mmHg, HR = 1.12 [1.06−1.18]). Significant associations were also observed for stroke, myocardial infarction, cardiovascular death, and all‐cause mortality. Conclusion: Both time‐weighted SBP and DBP independently influenced the risk of adverse cardiovascular events among patients with and without diabetes, regardless of the definition of hypertension (130/80 or <140/90 mmHg)

Identification of Renal Long Non-coding RNA RP11-2B6.2 as a Positive Regulator of Type I Interferon Signaling Pathway in Lupus Nephritis

Objective: Lupus nephritis (LN) is one of the most serious complications of systemic lupus erythematosus (SLE). Type I interferon (IFN-I) is associated with the pathogenesis of LN. Long non-coding RNAs (lncRNAs) have been implicated in the pathogenesis of SLE, however, the roles of lncRNAs in LN are still poorly understood. Here, we identified and investigated the function of LN-associated lncRNA RP11-2B6.2 in regulating IFN-I signaling pathway.Methods: RNA sequencing was used to analyze the expression of lncRNAs in kidney biopsies from LN patients and controls. Antisense oligonucleotides and CRISPRi system or overexpression plasmids and CRISPRa system were used to perform loss or gain of function experiments. In situ hybridization, imaging flow cytometry, dual-luciferase reporter assay, and ATAC sequencing were used to study the functions of lncRNA RP11-2B6.2. RT-qPCR, ELISA, and western blotting were done to detect RNA and protein levels of specific genes.Results: Elevated lncRNA RP11-2B6.2 was observed in kidney biopsies from LN patients and positively correlated with disease activity and IFN scores. Knockdown of lncRNA RP11-2B6.2 in renal cells inhibited the expression of IFN stimulated genes (ISGs), while overexpression of lncRNA RP11-2B6.2 enhanced ISG expression. Knockdown of LncRNA RP11-2B6.2 inhibited the phosphorylation of JAK1, TYK2, and STAT1 in IFN-I pathway, while promoted the chromatin accessibility and the transcription of SOCS1.Conclusion: The expression of lncRNAs is abnormal in the kidney of LN. LncRNA RP11-2B6.2 is a novel positive regulator of IFN-I pathway through epigenetic inhibition of SOCS1, which provides a new therapeutic target to alleviate over-activated IFN-I signaling in LN

Review of Pension Service Document Intelligent

Abstract Key words: Intelligent pension services; Ageing; review In recent years, the population aging into a period of accelerated development, population age of &quot;double&quot; the trend of pension services to bring huge challenges, to solve the old &quot;old in his time, and this paper, the old-aged&apos;s providing, teaching&quot; is gradually become a hot topic of us. Under this background, the intelligent pension services has become a response to ageing research frontier. Intelligent as a new type of old-age pension service situation, emphasizes the use of intelligent means to provide higher quality of care for the elderly. This paper summarizes the research situation of domestic and foreign literature, reviews the intelligent pension services of foreign and domestic policies, intelligent analysis expounds the relevant theories of pension services, finally, the intelligent reviews and outlooks the pension services

SnO(2)-Graphene composite synthesized via an ultrafast and environmentally friendly microwave autoclave method and its use as a superior anode for lithium-ion batteries

SnO2–graphene composites have been synthesized by an ultrafast and environmentally friendly microwave autoclave method. From field emission scanning electron microscopy and transmission electron microscopy, it can be determined that the SnO2 nanoparticles, around 4–5 nm in diameter, are uniformly sandwiched between graphene nanosheets containing only a few layers. The successful synthesis demonstrates that in situ loading of SnO2 nanoparticles can be an effective way to prevent graphene nanosheets from being restacked during the reduction. The Li-cycling properties of the materials have been evaluated by galvanostatic discharge–charge cycling and impedance spectroscopy. Results show that the SnO2–graphene composite with a graphene content of 33.3 wt % exhibits a very stable capacity of about 590 mA h g–1 without noticeable fading for up to 200 cycles

Three-dimensional nanocarbon and the electrochemistry of nanocarbon/tin oxide for lithium ion batteries

In this work, the potential of using coconut shell, which is very cheap and readily available, for the production of graphitic nanocarbon three-dimensional networks is investigated. The three-dimensional carbon has been produced via the wet-impregnation of coconut shell powder with a transition metal catalyst. The novel process employed offers low costs and environmental advantages, with biological waste used in place of carbonaceous precursor as the feedstock. Nanocarbon/tin oxide composites were prepared via wet-impregnation and the solvothermal method, using tin chloride solution with the activated nanocarbon. The electrochemical performances of the three-dimensional nanocarbon doped with tin oxide and of activated nanocarbon alone as anode materials were investigated in rechargeable lithium ion batteries. One composite made by using the solvothermal method shows stable cyclic retention up to 100 cycles and delivers a high reversible capacity of about 405 mAh g(-1)